title: The S128N mutation combined with an additional potential N-linked glycosylation site at residue 133 in hemagglutinin affects the antigenicity of the human H7N9 virus.
authors.affiliation: The Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region 830001, China.
authors.forename: Wanli
authors.initials: W
authors.lastname: Liu
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Tian
authors.initials: T
authors.lastname: Bai
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Jinlei
authors.initials: J
authors.lastname: Guo
authors.affiliation: The Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region 830001, China.
authors.forename: Xinlan
authors.initials: X
authors.lastname: Li
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Yang
authors.affiliation: The Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region 830001, China.
authors.forename: Xiaojun
authors.initials: X
authors.lastname: Wang
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Junfeng
authors.initials: J
authors.lastname: Guo
authors.affiliation: The Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region 830001, China.
authors.forename: Xin
authors.initials: X
authors.lastname: Ma
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Xiyan
authors.initials: X
authors.lastname: Li
authors.affiliation: The Center for Disease Control and Prevention, Urumqi, Xinjiang Uygur Autonomous Region 830001, China.
authors.forename: Hongbin
authors.initials: H
authors.lastname: Liu
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Jianfang
authors.initials: J
authors.lastname: Zhou
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Dayan
authors.initials: D
authors.lastname: Wang
authors.affiliation: National Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China.
authors.forename: Yue-Long
authors.initials: YL
authors.lastname: Shu
mesh_terms: D000368:Aged; D000956:Antigens, Viral / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D005260:Female; D006031:Glycosylation; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D064766:Influenza A Virus, H7N9 Subtype / Q000235:genetics* / Q000302:isolation & purification*; D007251:Influenza, Human / Q000821:virology; D009154:Mutation
chemical_list: D000956:Antigens, Viral; D019267:Hemagglutinin Glycoproteins, Influenza Virus